Structured evidence table for Almond LDL Cholesterol Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Almond LDL Cholesterol Meta-Analysis | Health Canada's Quality Appraisal Tool for Intervention Studies was used to assess each study's risk of bias. | 1 | Musa-Veloso K (2025) | Blood Lipid Levels in Response to Almond Consumption: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. |
| Almond LDL Cholesterol Meta-Analysis | Almond consumption significantly reduced LDL-C (-0.132 mmol/L; 95% CI: -0.190, -0.075 mmol/L; p p p p = 0.001), LDL-C:HDL-C (-0.112; 95% CI: -0.199, -0.026; p = 0.011), ApoB (-4.552 mg/dL; 95% CI: -6.460, -2.645 mg/dL; p p = 0.006), with a borderline significant reduction in TG (-0.037 mmol/L; 95% CI: -0.079, 0.005; p = 0.085) and no effects on HDL-C, ApoA, or Lp[a]. | 1 | Musa-Veloso K (2025) | Blood Lipid Levels in Response to Almond Consumption: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. |
| Almond LDL Cholesterol Meta-Analysis | Background/objectives While the benefits of almond consumption in reducing levels of TC and LDL-C are well established, the effects on additional lipids that have emerged as important predictors of cardiovascular disease, such as ApoB and the ratio of ApoB:ApoA, are not well characterized. | 1 | Musa-Veloso K (2025) | Blood Lipid Levels in Response to Almond Consumption: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. |
| Almond LDL Cholesterol Meta-Analysis | In this systematic review and meta-analysis, the effects of almond consumption on blood lipids were comprehensively assessed. | 1 | Musa-Veloso K (2025) | Blood Lipid Levels in Response to Almond Consumption: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. |
| Almond LDL Cholesterol Meta-Analysis | Conversely, a meta-analysis described in a report by the European Food Safety Authority (EFSA) on the tolerable upper intake level for dietary sugars identified a causal relationship with FS and risk of obesity and dyslipidemia from RCTs []. | 3 | Peregoy Jennifer A. (2026) | The Impact of Sugar Source on the Relationships Between Free Sugars Intake and Health: A Secondary Analysis |
| Almond LDL Cholesterol Meta-Analysis | However, data from prospective cohorts did not suggest a positive relationship between intake of FS and risk of obesity or dyslipidemia []. | 3 | Peregoy Jennifer A. (2026) | The Impact of Sugar Source on the Relationships Between Free Sugars Intake and Health: A Secondary Analysis |
| Almond LDL Cholesterol Meta-Analysis | Further, a 2025 meta-analysis of cohort studies found sugar-sweetened beverages (SSB), but not added sugars (nor total sugars), were related to increased risk of type 2 diabetes []. | 3 | Peregoy Jennifer A. (2026) | The Impact of Sugar Source on the Relationships Between Free Sugars Intake and Health: A Secondary Analysis |
| Almond LDL Cholesterol Meta-Analysis | 1 2 2 The value or threat of added and free sugars (FS) in the diet lacks scientific consensus. | 3 | Peregoy Jennifer A. (2026) | The Impact of Sugar Source on the Relationships Between Free Sugars Intake and Health: A Secondary Analysis |
Source documents